A total of 41 consecutive PCa patients (International Society of Urological Pathology Grade 1–2, PSA ≤ 15 ng/mL, ≤ cT2b) from November 2014 to July 2021 were included in the Miñana López B. et al. [26] study, which had a median follow-up of 36 months. Here, KLK3 is linked to posterior cortical atrophy.